Article Details
Retrieved on: 2022-10-05 08:24:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CFO David Kirske sold 139,841 shares of the firm's stock in a transaction on Friday, September 30th ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here